Speculative Application Shape the Future at Axolabs Join Axolabs Where Innovation Meets Impact in RNA Therapeutics Axolabs is a leader in developing a new class of medicines: oligonucleotide and nucleic acid therapeutics. These innovative drug modalities, derived from
Company Description Axolabs is a business unit of LGC, and a leading provider of CRO / CDMO capability to the therapeutic oligonucleotide discovery and development industry. Centred out of LGC’s site in Kulmbach, Germany, Axolabs works